Healthcare - 2Q20 Sector Overview

China Continuously Makes Efforts to Strengthen Domestic Medical Systems and Increase Medical Supplies

China has generally recovered from the initial COVID-19 outbreak in terms of day to day operations relative to the rest of the globe. To assist other countries in the fight against the pandemic, China has become the largest supplier of masks in the world, as well as exporting other medical-related equipment, such as protective suits, testing kits, and ventilators. Meanwhile, Chinese research institutes and pharmaceutical companies have devoted R&D to developing vaccines and drugs against the coronavirus.

In addition, the pharmaceutical and biotechnology industry overall has seen significant growth in the mainland stock market driven by the pandemic, and domestic companies in the sector are also actively seeking IPOs.

For more information about major Chinese healthcare sector highlights and events, download our Q2 China Healthcare Sector Overview.

Key Topics Covered:

State Administration for Market Regulation issues administration measures on drug registration, production supervision
Ministry of Civil Affairs releases revised elderly care institution administration rules for opinions
Chinese biotech companies are launching novel medical devices and technologies, most notably in oncology
The COVID-19 pandemic has bolstered more development of internet hospitals and online medical services

Complete the form to download the report

Quarterly Sector Overviews

Financial Reg